Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CT-Based Radiomics and Deep Learning for BRCA Mutation and Progression-Free Survival Prediction in Ovarian Cancer Using a Multicentric Dataset.
Avesani G, Tran HE, Cammarata G, Botta F, Raimondi S, Russo L, Persiani S, Bonatti M, Tagliaferri T, Dolciami M, Celli V, Boldrini L, Lenkowicz J, Pricolo P, Tomao F, Rizzo SMR, Colombo N, Manganaro L, Fagotti A, Scambia G, Gui B, Manfredi R. Avesani G, et al. Among authors: persiani s. Cancers (Basel). 2022 May 31;14(11):2739. doi: 10.3390/cancers14112739. Cancers (Basel). 2022. PMID: 35681720 Free PMC article.
Pretreatment MRI Radiomics Based Response Prediction Model in Locally Advanced Cervical Cancer.
Gui B, Autorino R, Miccò M, Nardangeli A, Pesce A, Lenkowicz J, Cusumano D, Russo L, Persiani S, Boldrini L, Dinapoli N, Macchia G, Sallustio G, Gambacorta MA, Ferrandina G, Manfredi R, Valentini V, Scambia G. Gui B, et al. Among authors: persiani s. Diagnostics (Basel). 2021 Mar 31;11(4):631. doi: 10.3390/diagnostics11040631. Diagnostics (Basel). 2021. PMID: 33807494 Free PMC article.
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R, Gui B, Panza G, Boldrini L, Cusumano D, Russo L, Nardangeli A, Persiani S, Campitelli M, Ferrandina G, Macchia G, Valentini V, Gambacorta MA, Manfredi R. Autorino R, et al. Among authors: persiani s. Radiol Med. 2022 May;127(5):498-506. doi: 10.1007/s11547-022-01482-9. Epub 2022 Mar 24. Radiol Med. 2022. PMID: 35325372 Free PMC article. Review.
MRI in the Evaluation of Locally Advanced Vulvar Cancer Treated with Chemoradiotherapy and Vulvar Cancer Recurrence: The 2021 Revision of FIGO Classification and the Need for Multidisciplinary Management.
Miccò M, Russo L, Persiani S, Dolciami M, Manganaro L, Cunha TM, Janicas C, Rizzo S, Nicolic O, Garganese G, Tagliaferri L, Lancellotta V, Scambia G, Manfredi R, Gui B. Miccò M, et al. Among authors: persiani s. Cancers (Basel). 2022 Aug 9;14(16):3852. doi: 10.3390/cancers14163852. Cancers (Basel). 2022. PMID: 36010846 Free PMC article. Review.
The role of apparent diffusion coefficient (ADC) in the evaluation of lymph node status in patients with locally advanced cervical cancer: our experience and a review.
Gui B, Russo L, Minordi L, Miccò M, Persiani S, Avesani G, Rufini V, Fuoco V, Autorino R, Ferrandina G, Scambia G, Manfredi R. Gui B, et al. Among authors: persiani s. Pol J Radiol. 2022 Aug 10;87:e438-e447. doi: 10.5114/pjr.2022.118914. eCollection 2022. Pol J Radiol. 2022. PMID: 36091653 Free PMC article.
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images.
Cusumano D, Russo L, Gui B, Autorino R, Boldrini L, D'Erme L, Persiani S, Catucci F, Broggi S, Panza G, Nardangeli A, Campitelli M, Ferrandina G, Macchia G, Fiorino C, Valentini V, Scambia G, Manfredi R, Gambacorta MA. Cusumano D, et al. Among authors: persiani s. Radiother Oncol. 2022 Sep;174:30-36. doi: 10.1016/j.radonc.2022.07.001. Epub 2022 Jul 8. Radiother Oncol. 2022. PMID: 35811004
MRI Staging in Locally Advanced Vulvar Cancer: From Anatomy to Clinico-Radiological Findings. A Multidisciplinary VulCan Team Point of View.
Gui B, Persiani S, Miccò M, Pignatelli V, Rodolfino E, Avesani G, Di Paola V, Panico C, Russo L, Fragomeni SM, Garganese G, Tagliaferri L, Scambia G, Manfredi R. Gui B, et al. Among authors: persiani s. J Pers Med. 2021 Nov 18;11(11):1219. doi: 10.3390/jpm11111219. J Pers Med. 2021. PMID: 34834571 Free PMC article. Review.
Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.
Caselli G, Bonazzi A, Lanza M, Ferrari F, Maggioni D, Ferioli C, Giambelli R, Comi E, Zerbi S, Perrella M, Letari O, Di Luccio E, Colovic M, Persiani S, Zanelli T, Mennuni L, Piepoli T, Rovati LC. Caselli G, et al. Among authors: persiani s. Arthritis Res Ther. 2018 Mar 1;20(1):39. doi: 10.1186/s13075-018-1537-8. Arthritis Res Ther. 2018. PMID: 29490676 Free PMC article.
59 results